Analgesics

Analyzing analgesics hinges on understanding their chemical nature. This section gives an overview of analgesics

General Properties of Analgesics

  • Definition: Analgesics are medications used to relieve pain
  • Classification: Analgesics can be classified into several categories based on their mechanism of action:
    • Opioids: Bind to opioid receptors in the central nervous system (e.g., morphine, codeine, oxycodone)
    • Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Inhibit cyclooxygenase (COX) enzymes (e.g., ibuprofen, naproxen, aspirin)
    • Acetaminophen: A centrally acting analgesic with antipyretic properties
    • Others: Atypical analgesics with various mechanisms of action (e.g., gabapentin, pregabalin, tramadol)
  • Common Properties
    • Analgesic Effect: Relieve pain
    • Anti-Inflammatory Effect: May reduce inflammation (NSAIDs)
    • Antipyretic Effect: May reduce fever (acetaminophen, NSAIDs)

Chemical Properties of Analgesics

  • Structural Diversity: Analgesics exhibit significant structural diversity, encompassing a wide range of chemical classes
  • Functional Groups: They contain various functional groups, such as hydroxyl, amino, carbonyl, and carboxyl groups, which influence their solubility, binding properties, and metabolism
  • Acidic or Basic Character: Acidic (NSAIDs) or basic (opioids) properties influence their behavior in biological systems
  • Chirality: Some analgesics are chiral molecules, existing as enantiomers or diastereomers with differing pharmacological activities
  • Chemical Stability: Varies widely depending on the specific drug and its formulation; storage conditions can affect stability

Physical Properties of Analgesics

  • Appearance: Crystalline solids or powders
  • Solubility: Varies depending on the specific drug and its chemical structure
  • Partition Coefficient (Log P): Indicates the relative affinity of a drug for lipid and aqueous phases
  • Ionization: Acidic or basic properties influence their absorption, distribution, and excretion
  • Protein Binding: Binding to plasma proteins (albumin, alpha-1-acid glycoprotein)
  • Melting Point: Characteristic property for identification and purity assessment
  • Hygroscopicity: Some analgesics are hygroscopic, absorbing moisture from the air

Specific Analgesic: Acetaminophen

  • Definition: Acetaminophen (also known as paracetamol) is a widely used over-the-counter analgesic and antipyretic drug
  • Chemical Structure: N-acetyl-p-aminophenol
  • Molecular Formula: \(C_8H_9NO_2\)
  • Molecular Weight: 151.16 g/mol
  • Appearance: White crystalline powder
  • Solubility: Slightly soluble in water (1.4 g/100 mL at 22°C), soluble in ethanol and methanol
  • pKa Value: 9.5 (weakly acidic)
  • Partition Coefficient (Log P): Approximately 0.46, indicating moderate polarity
  • Protein Binding: Relatively low protein binding (20-50%)
  • Melting Point: 169-170.5°C

Pharmacokinetic Implications

  • Absorption
    • Rapid and almost complete absorption after oral administration
    • Peak plasma concentrations are typically reached within 30-60 minutes
    • Absorption can be affected by gastric emptying rate and food intake
  • Distribution
    • Distributes rapidly and uniformly throughout most body tissues and fluids
    • Crosses the blood-brain barrier
  • Protein Binding
    • Relatively low protein binding (20-50%)
    • Changes in protein binding are usually not clinically significant
  • Metabolism
    • Primarily metabolized in the liver by:
      • Glucuronidation (55-60%)
      • Sulfation (20-30%)
      • CYP2E1-mediated oxidation to a reactive intermediate, N-acetyl-p-benzoquinone imine (NAPQI) (5-10%)
  • Excretion
    • Excreted primarily in the urine as glucuronide and sulfate conjugates
    • Small amounts are excreted unchanged
  • Half-Life
    • Half-life is approximately 1.5-3 hours in adults with normal liver function

Mechanism of Action

  • The exact mechanism of action of acetaminophen is not fully understood, but it is believed to involve:
    • Inhibition of cyclooxygenase (COX) enzymes in the brain: Selectively inhibits COX-2 in the CNS, reducing prostaglandin synthesis and pain/fever
    • Activation of the descending inhibitory serotonergic pathway
    • Inhibition of the endocannabinoid system

Structure-Activity Relationship (SAR)

  • The acetamide group is essential for activity
  • The para-aminophenol structure is important for its analgesic and antipyretic effects

Analytical Considerations in TDM

  • Analytical Methods
    • Spectrophotometry: Historically used, but less specific and sensitive
    • Immunoassays: Commonly used for routine TDM due to their ease of use and high throughput
      • Enzyme-multiplied immunoassay technique (EMIT)
      • Latex agglutination inhibition assay (LIA)
    • Chromatography: HPLC with UV or mass spectrometry detection is used for more specific and sensitive measurements
      • Liquid chromatography-tandem mass spectrometry (LC-MS/MS)
  • Sample Preparation
    • For immunoassays, serum or plasma can be analyzed directly or after simple dilution
    • For chromatographic methods, sample preparation may involve protein precipitation or solid-phase extraction (SPE)
  • Calibration and Quality Control
    • Use appropriate calibrators and quality control materials to ensure accurate and reliable results
  • Interferences
    • High bilirubin levels can interfere with some spectrophotometric assays
    • N-acetylcysteine (NAC), the antidote for acetaminophen overdose, can interfere with some immunoassays

Clinical Significance in TDM

  • Therapeutic Drug Monitoring (TDM)
    • TDM is not routinely used for acetaminophen, as it is a relatively safe drug at recommended doses
    • TDM is primarily used in cases of suspected overdose or liver toxicity to assess the risk of hepatotoxicity
  • Hepatotoxicity
    • Acetaminophen overdose can lead to severe liver damage and liver failure
    • NAPQI, a toxic metabolite, is normally detoxified by glutathione, but in overdose, glutathione stores are depleted, leading to liver damage
  • Rumack-Matthew Nomogram
    • A graph used to assess the risk of hepatotoxicity based on the serum acetaminophen concentration and the time since ingestion
  • Treatment for Acetaminophen Overdose
    • N-acetylcysteine (NAC): An antidote that replenishes glutathione stores and detoxifies NAPQI
  • Factors Affecting Toxicity
    • Dose: Higher doses increase the risk of hepatotoxicity
    • Time since ingestion: The risk of hepatotoxicity decreases with time
    • Liver function: Patients with pre-existing liver disease are at higher risk
    • Drug interactions: CYP2E1 inducers (e.g., alcohol, isoniazid) can increase NAPQI formation
    • Glutathione levels: Malnutrition or fasting can deplete glutathione stores
  • Non-linearity of Liver Function Tests (LFTs)
    • Severe toxicity may be underestimated if LFTs are not repeated since the elevation of LFTs is non-linear

Key Terms

  • Analgesics: Medications used to relieve pain
  • Acetaminophen: A widely used over-the-counter analgesic and antipyretic drug
  • Therapeutic Drug Monitoring (TDM): Measurement of drug concentrations to optimize therapy
  • Hepatotoxicity: Liver damage
  • NAPQI: N-acetyl-p-benzoquinone imine, a toxic metabolite of acetaminophen
  • Glutathione: An antioxidant that protects cells from damage
  • Rumack-Matthew Nomogram: A graph used to assess the risk of hepatotoxicity after acetaminophen overdose
  • N-acetylcysteine (NAC): An antidote for acetaminophen overdose
  • Bioavailability: The fraction of an administered dose of a drug that reaches the systemic circulation
  • Volume of Distribution: Apparent space in the body available to contain the drug
  • Protein Binding: The degree to which a drug binds to plasma proteins
  • Metabolism: The process by which the body chemically alters a drug
  • Excretion: The process by which the body eliminates a drug or its metabolites
  • Analgesic: A medicine used to relieve pain
  • Antipyretic: A medicine used to reduce fever